CVS Health (NYSE:CVS) Upgraded at Edward Jones

CVS Health (NYSE:CVS - Get Free Report) was upgraded by Edward Jones from a "hold" rating to a "buy" rating in a report issued on Thursday, Marketbeat.com reports.

A number of other research firms have also weighed in on CVS. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Truist Financial lowered their target price on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, TD Cowen increased their price objective on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $68.12.

CVS Health Price Performance

Shares of NYSE CVS traded down $0.41 during mid-day trading on Thursday, reaching $56.49. The company had a trading volume of 8,159,512 shares, compared to its average volume of 13,337,646. CVS Health has a one year low of $43.56 and a one year high of $80.75. The business's 50-day simple moving average is $51.28 and its 200 day simple moving average is $56.17. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm has a market cap of $71.08 billion, a price-to-earnings ratio of 14.39, a PEG ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 EPS. On average, research analysts predict that CVS Health will post 5.22 earnings per share for the current fiscal year.

Institutional Trading of CVS Health

Several institutional investors and hedge funds have recently modified their holdings of the business. State Street Corp raised its stake in shares of CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after acquiring an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC raised its holdings in CVS Health by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after purchasing an additional 461,569 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of CVS Health by 1.5% in the 3rd quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock worth $825,948,000 after purchasing an additional 198,920 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of CVS Health by 2.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after purchasing an additional 304,386 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its stake in CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after buying an additional 3,071,613 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.